Bellerophon Therapeutics (NASDAQ:BLPH) Now Covered by StockNews.com
Stock analysts at StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) in a note issued to investors on Monday. The brokerage set a “hold” rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance BLPH opened at $0.06 on Monday. Bellerophon Therapeutics has a fifty-two week low of $0.03 and […]